← Back to search

UH-OH LABS INC

SANTA CLARA, CA, 95054

UnclaimedClaim this profile (free)

Prime contracting experience

1 record from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
National Institutes of Health
AWARD A CONTRACT FOR RADX TECH TO UH-OH LABS - SARS-COV-2 LOOP-DE-LOOPTM ASSAY FOR HIGH-THROUGHPUT & POINT-OF-CARE USE—$14,982,258Jun 3, 2025Sep 30, 2021 – Dec 29, 2023

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Subcontracting experience

4 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Subcontractor
Department of Health and Human Services
THE KEY GOAL OF THIS PROGRAM IS TO DEVELOP A DESIGN-LOCKED VERSION OF STI SCOUT, AN IN VITRO DIAGNOSTIC (IVD) FOR THE DETECTION OF GONORRHEA AND CHLAMYDIA FROM MALE URINE AND FEMALE VAGINAL SWAB SAMPLES. THE TARGET PATHOGENS ARE NEISSERIA GONORRHOEAE AND CHLAMYDIA TRACHOMATIS. STI SCOUT WILL ENABLE PCR-LEVEL ACCURACY WITH THE CONVENIENCE AND COST OF RAPID ANTIGEN TESTING. COSTS OF GOODS SOLD ARE PROJECTED TO BE FAR LOWER THAN COMPETITIVE PRODUCTS, MAKING IT FINANCIALLY VIABLE TO ENTER GLOBAL LOW RESOURCE MARKETS. THE SCOUT PLATFORM INCLUDES A SCOUT HUB—A LOW-COST REUSABLE DEVICE—AND THE SCOUT CONNECT MOBILE APPLICATION FOR IOS AND ANDROID OS. TOGETHER, THESE ENABLE TESTING FOR A DEVELOPING MENU OF INDICATIONS, NOT JUST STIS, AND PERMIT RESULT TRACKING, SECURE SHARING, AND FOLLOW-ON CARE VIA TELEHEALTH. SCOUT WAS PREVIOUSLY AWARDED A CARB-X SEED AWARD CONTRACT TO DEMONSTRATE LOOP-DE-LOOP (LDL) CHEMISTRY WITH CRUDE PATIENT SAMPLES (URINE, VAGINAL SWABS). SCOUT SUCCESSFULLY COMPLETED ALL MILESTONES WITHIN THE SEED CONTRACT AND DEMONSTRATED ANALYTICAL PERFORMANCE IN POSITIVE AND PATIENT SPIKED SAMPLES THAT EXCEEDED THE TARGETS SET WITHIN THE CONTRACT. IN THIS DEVELOPMENT STAGE WORK, SCOUT WILL GENERATE ROBUST DATA AND DOCUMENTATION TO REACH DESIGN LOCK FOR STI SCOUT IN ADVANCE OF DOWNSTREAM FORMAL VERIFICATION AND VALIDATION ACTIVITIES THAT WILL EVENTUALLY SUPPORT A WHO PREQUALIFICATION AND US FDA 510(K) CLEARANCE. SCOUT WILL COMPLETE ASSAY DEVELOPMENT ACTIVITIES TO ENHANCE BOTH PERFORMANCE AND REGULATORY ALIGNMENT WITH WHO DRAFT TECHNICAL GUIDANCE. STI SCOUT PERFORMANCE AGAINST DESIGN INPUT REQUIREMENTS WILL BE ASSESSED ON THE INTEGRATED SCOUT SYSTEM (SCOUT HUB, SCOUT CONNECT APP) USING CONTROLLED TEST PROTOCOLS TO PROVIDE A SCIENTIFICALLY SOUND AND STATISTICALLY RIGOROUS EVALUATIONS. THE OUTCOME OF THIS PHASE WILL BE A CLEAR, DE-RISKED PATH TO INTERNATIONAL AND US COMMERCIALIZATION OF STI SCOUT, WITH SUPPORTING DOCUMENTATION AND EARLY PERFORMANCE AND USABILITY DATA TO INFORM FUTURE PIVOTAL STUDIES. IN ALIGNMENT WITH CARB-X’S MISSION TO COMBAT THE GROWING THREAT OF ANTIMICROBIAL RESISTANCE, SCOUT WILL ALSO ASSESS THE FEASIBILITY OF EXPANDING THE STI SCOUT PLATFORM TO DETECT NUCLEIC ACID MARKERS OF ANTIMICROBIAL RESISTANCE (AMR) ALONGSIDE PATHOGEN IDENTIFICATION.
KC4179
Parent award context
Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
Parent award NAICS: 541714
Parent award performance state: MA
Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA
View parent award on USAspending
—$1,250,000Oct 22, 2025— – —
Subcontractor
Department of Health and Human Services
THE KEY GOALS OF THIS PROGRAM ARE TO DEMONSTRATE DETECTION OF GONORRHEA FROM CRUDE VAGINAL SWAB AND URINE SAMPLES AND DEMONSTRATE PROOF-OF-FEASIBILITY FOR THE STI SCOUT, A PRODUCT INTENDED FOR AT HOME AND POINT-OF-NEED TESTING FOR GONORRHEA AND CHLAMYDIA. THE TARGET PATHOGENS ARE NEISSERIA GONORRHOEAE AND CHLAMYDIA TRACHOMATIS. THE KEY CLINICAL INDICATIONS ARE SYMPTOMATIC AND ASYMPTOMATIC INFECTIONS OR SUSPECTED INFECTIONS OF THE UROGENITAL TRACT BY CHLAMYDIA OR GONORRHEA, THE TWO MOST COMMON, TREATABLE SEXUALLY TRANSMITTED INFECTIONS IN THE UNITED STATES. SCOUT IS TARGETING DIFFERENTIATION AGAINST OTHER APPROACHES BY OFFERING PCR-LEVEL ACCURACY WITH THE CONVENIENCE AND COST OF RAPID ANTIGEN TESTING. UNLIKE COLLECT-AT-HOME AND SEND-IN TESTING OPTIONS, STI SCOUT DELIVERS RESULTS IMMEDIATELY TO THE USER (WITHIN 30 MINUTES). THE SCOUT HUB IS A REUSABLE DEVICE THAT ENABLES TESTING FOR MULTIPLE INDICATIONS, NOT JUST STIS, ADDING A VALUABLE TOOL TO INDIVIDUALS€„¢ OR CLINICS€„¢ TOOLKIT FOR DIAGNOSING COMMON, TREATABLE ILLNESSES OR INFORMING ON OVERALL WELLNESS. A MOBILE APPLICATION, SCOUT CONNECT, PERMITS RESULT TRACKING, SHARING, AND FOLLOW-ON CARE VIA TELEHEALTH AND E-PRESCRIPTIONS FROM QUALIFIED HEALTHCARE PROFESSIONALS. A PLANNED REFLEX TEST FOR NG AMR WILL ENABLE BETTER STEWARDSHIP OF ANTIBIOTICS.
4500004980
Parent award context
Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
Parent award NAICS: 541714
Parent award performance state: MA
Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA
View parent award on USAspending
—$44,117Feb 28, 2025— – —
Subcontractor
Department of Health and Human Services
THE KEY GOALS OF THIS PROGRAM ARE TO DEMONSTRATE DETECTION OF GONORRHEA FROM CRUDE VAGINAL SWAB AND URINE SAMPLES AND DEMONSTRATE PROOF-OF-FEASIBILITY FOR THE STI SCOUT, A PRODUCT INTENDED FOR AT HOME AND POINT-OF-NEED TESTING FOR GONORRHEA AND CHLAMYDIA. THE TARGET PATHOGENS ARE NEISSERIA GONORRHOEAE AND CHLAMYDIA TRACHOMATIS. THE KEY CLINICAL INDICATIONS ARE SYMPTOMATIC AND ASYMPTOMATIC INFECTIONS OR SUSPECTED INFECTIONS OF THE UROGENITAL TRACT BY CHLAMYDIA OR GONORRHEA, THE TWO MOST COMMON, TREATABLE SEXUALLY TRANSMITTED INFECTIONS IN THE UNITED STATES. SCOUT IS TARGETING DIFFERENTIATION AGAINST OTHER APPROACHES BY OFFERING PCR-LEVEL ACCURACY WITH THE CONVENIENCE AND COST OF RAPID ANTIGEN TESTING. UNLIKE COLLECT-AT-HOME AND SEND-IN TESTING OPTIONS, STI SCOUT DELIVERS RESULTS IMMEDIATELY TO THE USER (WITHIN 30 MINUTES). THE SCOUT HUB IS A REUSABLE DEVICE THAT ENABLES TESTING FOR MULTIPLE INDICATIONS, NOT JUST STIS, ADDING A VALUABLE TOOL TO INDIVIDUALS€„¢ OR CLINICS€„¢ TOOLKIT FOR DIAGNOSING COMMON, TREATABLE ILLNESSES OR INFORMING ON OVERALL WELLNESS. A MOBILE APPLICATION, SCOUT CONNECT, PERMITS RESULT TRACKING, SHARING, AND FOLLOW-ON CARE VIA TELEHEALTH AND E-PRESCRIPTIONS FROM QUALIFIED HEALTHCARE PROFESSIONALS. A PLANNED REFLEX TEST FOR NG AMR WILL ENABLE BETTER STEWARDSHIP OF ANTIBIOTICS.
4500004980
Parent award context
Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
Parent award NAICS: 541714
Parent award performance state: MA
Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA
View parent award on USAspending
—-$200,000Nov 26, 2024— – —
Subcontractor
Department of Health and Human Services
THE KEY GOALS OF THIS PROGRAM ARE TO DEMONSTRATE DETECTION OF GONORRHEA FROM CRUDE VAGINAL SWAB AND URINE SAMPLES AND DEMONSTRATE PROOF-OF-FEASIBILITY FOR THE STI SCOUT, A PRODUCT INTENDED FOR AT HOME AND POINT-OF-NEED TESTING FOR GONORRHEA AND CHLAMYDIA. THE TARGET PATHOGENS ARE NEISSERIA GONORRHOEAE AND CHLAMYDIA TRACHOMATIS. THE KEY CLINICAL INDICATIONS ARE SYMPTOMATIC AND ASYMPTOMATIC INFECTIONS OR SUSPECTED INFECTIONS OF THE UROGENITAL TRACT BY CHLAMYDIA OR GONORRHEA, THE TWO MOST COMMON, TREATABLE SEXUALLY TRANSMITTED INFECTIONS IN THE UNITED STATES. SCOUT IS TARGETING DIFFERENTIATION AGAINST OTHER APPROACHES BY OFFERING PCR-LEVEL ACCURACY WITH THE CONVENIENCE AND COST OF RAPID ANTIGEN TESTING. UNLIKE COLLECT-AT-HOME AND SEND-IN TESTING OPTIONS, STI SCOUT DELIVERS RESULTS IMMEDIATELY TO THE USER (WITHIN 30 MINUTES). THE SCOUT HUB IS A REUSABLE DEVICE THAT ENABLES TESTING FOR MULTIPLE INDICATIONS, NOT JUST STIS, ADDING A VALUABLE TOOL TO INDIVIDUALS€„¢ OR CLINICS€„¢ TOOLKIT FOR DIAGNOSING COMMON, TREATABLE ILLNESSES OR INFORMING ON OVERALL WELLNESS. A MOBILE APPLICATION, SCOUT CONNECT, PERMITS RESULT TRACKING, SHARING, AND FOLLOW-ON CARE VIA TELEHEALTH AND E-PRESCRIPTIONS FROM QUALIFIED HEALTHCARE PROFESSIONALS. A PLANNED REFLEX TEST FOR NG AMR WILL ENABLE BETTER STEWARDSHIP OF ANTIBIOTICS.
4500004980
Parent award context
Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
Parent award NAICS: 541714
Parent award performance state: MA
Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA
View parent award on USAspending
—$400,000Mar 26, 2024— – —

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.

UH-OH LABS INC – Santa Clara, CA | UEI SJNBW82KEKL7 | FedSub